Zobrazeno 1 - 10
of 53
pro vyhledávání: '"Susana, Bizarro"'
Autor:
Nuno Cerveira, Bruno Loureiro, Susana Bizarro, Cecília Correia, Lurdes Torres, Susana Lisboa, Joana Vieira, Rui Santos, Dulcineia Pereira, Cláudia Moreira, Sérgio Chacim, Nélson Domingues, Ana Espírito-Santo, Isabel Oliveira, Ilídia Moreira, Luísa Viterbo, Ângelo Martins, Manuel R. Teixeira, José M. Mariz
Publikováno v:
BMC Cancer, Vol 18, Iss 1, Pp 1-10 (2018)
Abstract Background Most patients with chronic myeloid leukemia (CML) treated with tyrosine kinase inhibitors (TKIs) will relapse if treatment is withdrawn, but various trials have recently demonstrated that a significant proportion of patients who a
Externí odkaz:
https://doaj.org/article/844beabb6bfa4c04860691966de11379
Autor:
Nuno Cerveira, Rosa Branca Ferreira, Susana Bizarro, Cecília Correia, Lurdes Torres, Susana Lisboa, Joana Vieira, Rui Santos, Fernando Campilho, Carlos Pinho Vaz, Luís Leite, Manuel R. Teixeira, António Campos
Publikováno v:
BMC Cancer, Vol 18, Iss 1, Pp 1-5 (2018)
Abstract Background Atypical BCR-ABL1 transcripts are detected in less than 5% of patients diagnosed with chronic myeloid leukaemia (CML), of which e19a2 is the most frequently observed, with breakpoints in the micro breakpoint cluster region (μ-BCR
Externí odkaz:
https://doaj.org/article/db074203b03449e28d051182f4025ac3
Autor:
Maria Eduarda Couto, Susana Bizarro, Domingos Sousa, Nelson Domingues, Isabel Oliveira, Gabriela Martins, Manuel R. Teixeira, Mário Mariz
Publikováno v:
Case Reports in Hematology, Vol 2020 (2020)
Chronic lymphocytic leukemia (CLL) is frequently an indolent diagnosis, with most of the patients being under surveillance for long time. There is an increased risk of a second neoplasia in CLL, rarely hematological (in the myeloid lineage is even ra
Externí odkaz:
https://doaj.org/article/cc8e88914c6a4c7aa4be6279de89e62a
Autor:
Pedro Pinto, Manuel R. Teixeira, Rui Santos, João Silva, Catarina Santos, Ana Peixoto, Carla Escudeiro, Susana Bizarro, Joana Guerra, Carla M. A. Pinto, Manuela Pinheiro
Publikováno v:
Cancer Genetics. :18-24
The genomic consequence and clinical interpretation of large duplications are difficult to infer without determining the location and orientation of the duplicated sequence. We aimed to characterize two intragenic duplications detected in two heredit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f68ec3d47ec63bf52bc846c15e7216d9
https://doi.org/10.1016/j.cancergen.2020.09.001
https://doi.org/10.1016/j.cancergen.2020.09.001
Publikováno v:
Current Treatment Options in Oncology. 22
ABL1 tyrosine kinase inhibitors (TKI) have dramatically improved the outcome for CML (chronic myeloid leukemia) patients. When TKI therapy is addressed appropriately, it can lead to an optimal molecular response in the majority of CML patients and a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0752283d40b91a887ccfccfa28c203f7
https://doi.org/10.1007/s11864-021-00851-2
https://doi.org/10.1007/s11864-021-00851-2
Autor:
Domingos Sousa, Maria Eduarda Couto, Gabriela Martins, Nelson Domingues, Mário Mariz, Isabel Oliveira, Susana Bizarro, Manuel R. Teixeira
Publikováno v:
Case Reports in Hematology
Case Reports in Hematology, Vol 2020 (2020)
Case Reports in Hematology, Vol 2020 (2020)
Chronic lymphocytic leukemia (CLL) is frequently an indolent diagnosis, with most of the patients being under surveillance for long time. There is an increased risk of a second neoplasia in CLL, rarely hematological (in the myeloid lineage is even ra
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c86b2e9e46fb945259b31fb040a7c2af
http://europepmc.org/articles/PMC7769667
http://europepmc.org/articles/PMC7769667
Autor:
Nuno Cerveira, Francesca Micci, Joana Santos, Manuela Pinheiro, Cecília Correia, Susana Lisboa, Susana Bizarro, Lucília Norton, Anders Glomstein, Ann E. Åsberg, Sverre Heim, Manuel R. Teixeira
Publikováno v:
Haematologica, Vol 93, Iss 7 (2008)
One of the MLL fusion partners in leukemia is the SEPT6 gene, which belongs to the evolutionarily conserved family of genes of septins. In this work we aimed to characterize at both the RNA and DNA levels three acute myeloid leukemias with cytogeneti
Externí odkaz:
https://doaj.org/article/3e0f340ff624444fbd158ed5e31b97c5
Autor:
Nuno, Cerveira, Joana, Diamond, Sónia, Matos, Maria L, Amorim, Margarida, Coucelo, Susana, Bizarro, Ana Teresa, Simões, Francesca, Pierdomenico, Mariana, Lopes, Letícia, Ribeiro, Maria, do Carmo-Fonseca, José E, Guimarães, António, Almeida, Manuel R, Teixeira
Publikováno v:
British journal of haematology. 186(6)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::67215d911e59ceefc100bb0253aba143
https://pubmed.ncbi.nlm.nih.gov/31218669
https://pubmed.ncbi.nlm.nih.gov/31218669
Autor:
Maria Carmo-Fonseca, Nuno Cerveira, Jose E. Guimaraes, Francesca Pierdomenico, Ana Teresa Simões, Joana Diamond, Mariana Lopes, Sonia Matos, Margarida Coucelo, Manuel R. Teixeira, Susana Bizarro, Antonio Almeida, Letícia Ribeiro, Maria Luís Amorim
Publikováno v:
Repositório Científico de Acesso Aberto de Portugal
Repositório Científico de Acesso Aberto de Portugal (RCAAP)
instacron:RCAAP
Repositório Científico de Acesso Aberto de Portugal (RCAAP)
instacron:RCAAP
© 2019 British Society for Haematology and John Wiley & Sons Ltd.
ABL1 tyrosine kinase inhibitors (TKI) have dramatically improved the outcome for chronic myeloid leukaemia (CML) patients, resulting in a life expectancy that approaches that of
ABL1 tyrosine kinase inhibitors (TKI) have dramatically improved the outcome for chronic myeloid leukaemia (CML) patients, resulting in a life expectancy that approaches that of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7fe5caf04a9875ef03068a35a029f6de
https://hdl.handle.net/10451/49215
https://hdl.handle.net/10451/49215
Autor:
Cecília Correia, Lurdes Torres, Susana Lisboa, Rui Santos, Susana Bizarro, Joana Vieira, Nuno Cerveira, Antonio Campos, Manuel R. Teixeira, Fernando Campilho, Carlos Pinho Vaz, Luís Leite, Rosa Branca Ferreira
Publikováno v:
BMC Cancer
BMC Cancer, Vol 18, Iss 1, Pp 1-5 (2018)
BMC Cancer, Vol 18, Iss 1, Pp 1-5 (2018)
Background Atypical BCR-ABL1 transcripts are detected in less than 5% of patients diagnosed with chronic myeloid leukaemia (CML), of which e19a2 is the most frequently observed, with breakpoints in the micro breakpoint cluster region (μ-BCR) and cod
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::33906da6df1f5f4bfbf174950ed2c12e
http://europepmc.org/articles/PMC6286606
http://europepmc.org/articles/PMC6286606